Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:OPHT

IVERIC bio (OPHT) Stock Price, News & Analysis

IVERIC bio logo

About IVERIC bio Stock (NASDAQ:OPHT)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.13
$1.39
52-Week Range
N/A
Volume
N/A
Average Volume
159,109 shs
Market Capitalization
$1.65 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OPHT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IVERIC bio and its competitors with MarketBeat's FREE daily newsletter.

OPHT Stock News Headlines

Gossamer Bio Inc GOSS
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
Baird Downgrades IVERIC bio (ISEE)
See More Headlines

OPHT Stock Analysis - Frequently Asked Questions

IVERIC bio, Inc. (NASDAQ:OPHT) posted its quarterly earnings data on Wednesday, October, 31st. The biopharmaceutical company reported ($0.41) EPS for the quarter, topping the consensus estimate of ($0.43) by $0.02.

Based on aggregate information from My MarketBeat watchlists, some other companies that IVERIC bio investors own include iShares Preferred and Income Securities ETF (PFF), Puma Biotechnology (PBYI), Incyte (INCY), Apollo Investment (AINV), BioMarin Pharmaceutical (BMRN), Meta Platforms (META) and Bristol Myers Squibb (BMY).

Company Calendar

Last Earnings
10/31/2018
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:OPHT
CIK
1410939
Fax
N/A
Employees
35
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.67)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$63.09 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-141.53%
Return on Assets
-41.88%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
10.09
Quick Ratio
10.09

Sales & Book Value

Annual Sales
$209.98 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.00 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
41,420,000
Free Float
N/A
Market Cap
$1.65 billion
Optionable
Optionable
Beta
1.49
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:OPHT) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners